Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 19, Number 12—December 2013

Research

Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009

Gregory P. Giambrone1Comments to Author , Shelley M. Zansky, Millicent Eidson, Pamela G. Duncan, Louise-Anne McNutt, and Guthrie S. Birkhead
Author affiliations: New York State Department of Health, Albany, New York, USA (G.P. Giambrone, S.M. Zansky, M. Eidson, P.G. Duncan, G.S. Birkhead); University at Albany School of Public Health, Rensselaer, New York, USA (L.-A. McNutt, G.S. Birkhead)

Main Article

Table 2

Use of primary and secondary diagnosis codes for GBS identified by SPARCS, New York State Department of Health GBS surveillance system, 2009–2010*

Diagnosis
Total cases reported
Confirmed/probable cases, no. (%)
Primary 149 116 (78)
Secondary 70 14 (20)
Total 219 130 (59)

*GBS, Guillain-Barré syndrome; SPARCS, Statewide Planning and Research Cooperative System. SPARCS collects administrative data on all hospital discharges in state facilities.

Main Article

1Current affiliation: Weill Cornell Medical College, New York, New York, USA.

TOP